Longitudinal expression profiling identifies a poor risk subset of patients with ABC-type Diffuse Large B Cell Lymphoma View External Link Categories Peer Reviewed Publications Topics: ABC- type diffuse large B-cell lymphoma DLBCL COO immuno-oncology agents targeted therapeutics